The metabolic cost of lowering blood pressure with hydrochlorothiazide

BACKGROUND: The landmark Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) placed a new spotlight on thiazide diuretics as the first-line therapy for hypertension. This is concerning as thiazide-diuretics may contribute to comorbidities associated with the current...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Angela L, Lingvay, Ildiko, Szczepaniak, Edward W, Wiebel, Jaime, Victor, Ronald G, Szczepaniak, Lidia S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711837/
https://www.ncbi.nlm.nih.gov/pubmed/23837919
http://dx.doi.org/10.1186/1758-5996-5-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711837/
https://www.ncbi.nlm.nih.gov/pubmed/23837919
http://dx.doi.org/10.1186/1758-5996-5-35

Ejemplares similares